MANAGEMENT OF NAUSEA AND VOMITING IN THE CANCER-PATIENT

被引：94
作者：
FRYTAK, S
MOERTEL, CG
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1981年 / 245卷 / 04期
关键词：
D O I：
10.1001/jama.245.4.393
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：393 / 396
页数：4
相关论文
共 19 条
[1]  
CHANG A, UNPUBLISHED
[2]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].
CHANG, AE ;
SHILING, DJ ;
STILLMAN, RC ;
GOLDBERG, NH ;
SEIPP, CA ;
BAROFSKY, I ;
SIMON, RM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824
[3]  
COLLS BM, 1980, NEW ZEAL MED J, V91, P449
[4]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC FOR PATIENTS RECEIVING CANCER-CHEMOTHERAPY - COMPARISON WITH PROCHLORPERAZINE AND A PLACEBO [J].
FRYTAK, S ;
MOERTEL, CG ;
OFALLON, JR ;
RUBIN, J ;
CREAGAN, ET ;
OCONNELL, MJ ;
SCHUTT, AJ ;
SCHWARTAU, NW .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :825-830
[5]  
KHAN T, 1978, CANCER TREAT REP, V62, P1106
[6]  
KLUINNELEMAN JC, 1979, VET HUM TOXICOL, V21, P338
[7]   DELTA-9-TETRAHYDROCANNABINOL FOR REFRACTORY VOMITING INDUCED BY CANCER-CHEMOTHERAPY [J].
LUCAS, VS ;
LASZLO, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (12) :1241-1243
[8]  
LUTZ H, 1972, CURR THER RES CLIN E, V14, P178
[9]  
MOERTEL CG, 1969, GASTROENTEROLOGY, V57, P262
[10]  
MOERTEL CG, 1969, ADV GASTROINTESTINAL, P38
12